Accenture CEO Julie Sweet Childhood Pic

Accenture CEO Julie Sweet diagnosed with cancer

Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events

Diane Brady on how CEOs should handle a cancer diagnosis. The big story: Reciprocal trade tariffs. The markets: Approaching all-time highs, again. Analyst notes from JP Morgan, Goldman Sachs, Wedbush.

The Times of India on MSN · 2d

Accenture CEO Julie Sweet diagnosed with cancer, to undergo surgery next week

Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable condition, she will undergo surgery and radiation treatment while continuing her leadership role with reduced travel.

The Daily Beast on MSN · 1d

Accenture CEO’s Cancer Diagnosis Gives Insight Into How Execs Divulge Illness

Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare insight into how executives disclose their life-altering health news. Sweet,

Investing.com on MSN · 2d

Accenture CEO Julie Sweet shares health update

Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer. In a message to all Accenture employees,

Inc27d

Exclusive Conversation Between Accenture CEO Julie Sweet and David Droga: How A ‘Ridiculous’ Leadership Idea Led to a Remarkable Outcome

Hello and welcome to Modern CEO! I’m Stephanie Mehta, CEO and chief content officer of Mansueto Ventures. Each week this newsletter explores inclusive approaches to leadership drawn from ...

Fast Company27d

Why creativity is key: The Julie Sweet and David Droga formula at Accenture

Stephanie Mehta, CEO and COO of Mansueto Ventures, publisher of ‘Inc.’ and ‘Fast Company,’ sat down with Accenture leaders, David Droga and Julie Sweet, to discuss how they are reinventing ...

HR Dive2d

Accenture rolls back DEI goals to comply with Trump’s EOs

CEO Julie Sweet said the company would end its employee diversity representation goals and put “a greater focus on inclusion and a sense of belonging for all,” in an internal memo.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Accenture CEO Julie Sweet diagnosed with cancer

Trending now